GuidelineInternational journal of clinical oncology2020

Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.

Yoichi Naito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.